Amanta Healthcare Limited (NSE:AMANTA)
India · Delayed Price · Currency is INR 104.24
+3.62 (3.60%)
At close: Jan 21, 2026
Amanta Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 2,761 | 2,747 | 2,803 | 2,591 | 2,254 | 1,713 | Upgrade |
| 2,761 | 2,747 | 2,803 | 2,591 | 2,254 | 1,713 | Upgrade | |
Revenue Growth (YoY) | -1.52% | -2.01% | 8.19% | 14.94% | 31.61% | -7.09% | Upgrade |
Cost of Revenue | 883.34 | 948.23 | 1,051 | 1,018 | 767.95 | 495.25 | Upgrade |
Gross Profit | 1,877 | 1,799 | 1,752 | 1,574 | 1,486 | 1,218 | Upgrade |
Selling, General & Admin | 394.99 | 363.88 | 326.12 | 326.62 | 292.41 | 364.72 | Upgrade |
Other Operating Expenses | 863.04 | 838.28 | 851.33 | 715.02 | 657.78 | 468.09 | Upgrade |
Operating Expenses | 1,443 | 1,386 | 1,375 | 1,225 | 1,123 | 1,003 | Upgrade |
Operating Income | 434.31 | 412.7 | 377.6 | 348.57 | 363.49 | 214.66 | Upgrade |
Interest Expense | -226.35 | -269.66 | -323.97 | -343.85 | -430.58 | -380.93 | Upgrade |
Interest & Investment Income | 3.09 | 3.09 | 3.29 | 8.05 | 3.35 | 6.5 | Upgrade |
Currency Exchange Gain (Loss) | 0.68 | 0.68 | - | 18.98 | 3.17 | 2.82 | Upgrade |
Other Non Operating Income (Expenses) | -1.18 | -7.97 | -5.87 | -8.52 | -8.36 | -20.38 | Upgrade |
EBT Excluding Unusual Items | 210.55 | 138.84 | 51.05 | 23.23 | -68.93 | -177.33 | Upgrade |
Gain (Loss) on Sale of Investments | 5.01 | 5.01 | 2.48 | 1.33 | 1.31 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | -4.64 | - | -1.53 | Upgrade |
Other Unusual Items | -24.44 | 1.85 | - | 5.34 | 685.23 | 0.67 | Upgrade |
Pretax Income | 192.49 | 147.07 | 53.89 | 26.9 | 617.87 | -177.56 | Upgrade |
Income Tax Expense | 59.28 | 42.06 | 17.56 | 48.01 | 79.06 | 40.78 | Upgrade |
Net Income | 133.2 | 105.01 | 36.33 | -21.11 | 538.82 | -218.34 | Upgrade |
Net Income to Common | 133.2 | 105.01 | 36.33 | -21.11 | 538.82 | -218.34 | Upgrade |
Net Income Growth | 266.63% | 189.02% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 31 | 28 | 27 | 27 | 27 | 27 | Upgrade |
Shares Outstanding (Diluted) | 31 | 28 | 27 | 27 | 27 | 27 | Upgrade |
Shares Change (YoY) | 16.80% | 5.37% | -0.00% | - | 0.00% | - | Upgrade |
EPS (Basic) | 4.25 | 3.71 | 1.35 | -0.79 | 20.08 | -8.14 | Upgrade |
EPS (Diluted) | 4.25 | 3.71 | 1.35 | -0.79 | 20.08 | -8.14 | Upgrade |
EPS Growth | 214.59% | 174.81% | - | - | - | - | Upgrade |
Free Cash Flow | 243.79 | 258.46 | 446.62 | 362.9 | 535.62 | 199.08 | Upgrade |
Free Cash Flow Per Share | 7.78 | 9.14 | 16.65 | 13.53 | 19.96 | 7.42 | Upgrade |
Gross Margin | 68.00% | 65.48% | 62.51% | 60.73% | 65.94% | 71.09% | Upgrade |
Operating Margin | 15.73% | 15.02% | 13.47% | 13.45% | 16.12% | 12.53% | Upgrade |
Profit Margin | 4.83% | 3.82% | 1.30% | -0.81% | 23.90% | -12.75% | Upgrade |
Free Cash Flow Margin | 8.83% | 9.41% | 15.93% | 14.00% | 23.76% | 11.62% | Upgrade |
EBITDA | 601.13 | 578.47 | 548.72 | 513.77 | 527.72 | 384.06 | Upgrade |
EBITDA Margin | 21.77% | 21.06% | 19.57% | 19.83% | 23.41% | 22.42% | Upgrade |
D&A For EBITDA | 166.81 | 165.77 | 171.12 | 165.2 | 164.24 | 169.4 | Upgrade |
EBIT | 434.31 | 412.7 | 377.6 | 348.57 | 363.49 | 214.66 | Upgrade |
EBIT Margin | 15.73% | 15.02% | 13.47% | 13.45% | 16.12% | 12.53% | Upgrade |
Effective Tax Rate | 30.80% | 28.60% | 32.58% | 178.46% | 12.80% | - | Upgrade |
Revenue as Reported | 2,780 | 2,760 | 2,816 | 2,627 | 2,263 | 1,724 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.